The Latest Analyst Ratings For Molina Healthcare

Analysts' ratings for Molina Healthcare MOH over the last quarter vary from bullish to bearish, as provided by 4 analysts.

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 2 2 0 0
Last 30D 0 0 1 0 0
1M Ago 0 1 0 0 0
2M Ago 0 1 0 0 0
3M Ago 0 0 1 0 0

Analysts have set 12-month price targets for Molina Healthcare, revealing an average target of $374.0, a high estimate of $392.00, and a low estimate of $350.00. This current average reflects an increase of 4.32% from the previous average price target of $358.50.

price target chart

Exploring Analyst Ratings: An In-Depth Overview

A clear picture of Molina Healthcare's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Kevin Caliendo UBS Raises Neutral $380.00 $350.00
Sarah James Cantor Fitzgerald Maintains Overweight $374.00 -
Calvin Sternick JP Morgan Raises Overweight $392.00 $367.00
Scott Fidel Stephens & Co. Maintains Equal-Weight $350.00 -

Key Insights:

  • Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Molina Healthcare. This offers insight into analysts' perspectives on the current state of the company.
  • Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Molina Healthcare compared to the broader market.
  • Price Targets: Analysts predict movements in price targets, offering estimates for Molina Healthcare's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.

For valuable insights into Molina Healthcare's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.

Stay up to date on Molina Healthcare analyst ratings.

Delving into Molina Healthcare's Background

Molina Healthcare Inc offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization (HMO). In addition to its Health Plans segment, Molina has a Medicaid,Medicare, and Marketplace segment that represent the government-funded or sponsored programs under their management information systems. Molina's Medicaid plans receive revenue on a per-member per-month basis from state government agencies, and its Medicare Advantage plans receive revenue from managed care plans that contract with the Centers for Medicaid and Medicare (CMS). Molina also provides plans through health insurance exchanges.

Financial Milestones: Molina Healthcare's Journey

Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.

Revenue Growth: Molina Healthcare's remarkable performance in 3 months is evident. As of 30 September, 2023, the company achieved an impressive revenue growth rate of 7.83%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.

Net Margin: Molina Healthcare's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.87% net margin, the company effectively manages costs and achieves strong profitability.

Return on Equity (ROE): Molina Healthcare's ROE excels beyond industry benchmarks, reaching 6.53%. This signifies robust financial management and efficient use of shareholder equity capital.

Return on Assets (ROA): Molina Healthcare's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.72% ROA, the company effectively utilizes its assets for optimal returns.

Debt Management: Molina Healthcare's debt-to-equity ratio surpasses industry norms, standing at 0.61. This suggests the company carries a substantial amount of debt, posing potential financial challenges.

The Basics of Analyst Ratings

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!